Zobrazeno 1 - 10
of 1 813
pro vyhledávání: '"Mikhailidis, D.P"'
Autor:
Giannopoulos, A., Kakkos, S., Abbott, A., Naylor, A.R., Richards, T., Mikhailidis, D.P., Geroulakos, G., Nicolaides, A.N.
Publikováno v:
In European Journal of Vascular & Endovascular Surgery November 2015 50(5):573-582
Publikováno v:
In Journal of Diabetes and Its Complications July-August 2014 28(4):573-579
Publikováno v:
In European Journal of Vascular & Endovascular Surgery June 2013 45(6):539-545
Publikováno v:
In Public Health May 2013 127(5):435-441
Background: Venous Thromboembolism (VTE) is common among patients with severe Coronavirus Disease 2019 (COVID-19). Anticoagulation in hospitalized COVID-19 patients has been associated with survival benefit; however, the optimal thromboprophylaxis st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::09293cf05ded9a5303ce93c8a6547d2b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020074
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020074
International guidelines strongly recommend statins alone or in combination with other lipid-lowering agents to lower low-density lipoprotein cholesterol (LDL-C) levels for patients with asymptomatic/symptomatic carotid stenosis (AsxCS/SCS). Lowering
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::50768c5a5d75dc0d2895c5d705c93be3
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220676
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220676
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hatzitolios, A.I., Athyros, V.G., Karagiannis, A., Savopoulos, C., Charalambous, C., Kyriakidis, G., Milidis, Th., Papathanakis, C., Bitli, A., Vogiatsis, I., Ntaios, G., Katsiki, N., Symeonidis, A., Tziomalos, K., Mikhailidis, D.P.
Publikováno v:
In International Journal of Cardiology 2009 134(3):322-329
Aim: We evaluated the lipid-lowering (LL) effect of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) in patients with heterozygous familial hypercholesterolemia (HeFH) treated with LL-drugs and lipoprotein apheresis (LA). Patients an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::b8e163586a3c881dcc2607ee693f8b04
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020594
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020594
Hyperuricemia, has been traditionally related to nephrolithiasis and gout. However, it has also been associated with the development of type 2 diabetes mellitus (T2DM) and cardiometabolic and cardiovascular diseases. Pathophysiologically, elevated se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::c8859ee0d61b2405ff893a1d06af6913
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020512
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3020512